If you’re suffering from joint pain, you’ve probably tried everything — from over-the-counter pain relievers to prescription medications that come with dangerous side effects.
What if I told you that three of the most effective natural solutions for joint pain have been systematically removed from the market? And it’s not because they didn’t work — in many cases, it’s because they worked TOO WELL.
While pharmaceutical companies rake in BILLIONS selling expensive prescription drugs, these 3 banned supplements could have provided lasting joint relief at a fraction of the cost.
1. Red Yeast Rice (Cholestin)
Red yeast rice has been used in traditional Chinese medicine for centuries. It contains naturally occurring lovastatin — the EXACT SAME compound found in prescription cholesterol medications.
Here’s the shocking part: The FDA banned the original Cholestin formula not because it was dangerous (they admitted it wasn’t), but because it contained the same ingredient as Merck’s blockbuster cholesterol-lowering drug Mevacor.
That’s right — a natural supplement that helped reduce inflammation and improve circulation was essentially banned because it threatened pharmaceutical profits.
When inflammation is reduced and circulation improves, your joints receive more healing nutrients and oxygen. This could have been a game-changer for joint pain sufferers.
2. DMSO (Dimethyl Sulfoxide)
DMSO is perhaps one of the most versatile healing substances ever discovered. This remarkable compound can penetrate the skin instantly, delivering powerful anti-inflammatory and pain-relieving effects directly to your joints.
Despite decades of evidence and numerous studies showing its effectiveness for arthritis and chronic pain, the FDA severely restricted DMSO to a single approved use — a rare bladder condition.
Why? Some point to those early animal studies from the 1960s, but others suggest a more troubling reason: DMSO is inexpensive, can’t be patented, and would compete with profitable prescription pain medications.
Thousands of joint pain sufferers report dramatic relief when using DMSO for topical application. Yet most doctors won’t even mention it as an option.
3. Androstenedione (“Andro”)
While controversial due to its use by athletes, many forget that Androstenedione was originally marketed as a supplement to help middle-aged and older adults maintain healthy testosterone levels.
Proper hormone balance, including testosterone, plays a crucial role in maintaining muscle mass and joint health as we age. When our hormone levels drop, our muscles weaken, placing more strain on our joints.
In 2004, Andro was reclassified from a dietary supplement to an anabolic steroid, effectively banning the world’s top performing testosterone booster by removing its over-the-counter access.
It was a tragic move that still resonates today more than 20 years later. Androstenedione was an easy-to-swallow tablet that boosted testosterone in a reliable and systematic way that has never been matched since. Even testosterone shots and creams can’t match its effectiveness and track record.
The Hidden Problem Behind Your Joint Pain…
And What You can Do RIGHT NOW
While these banned supplements could have helped many people, there’s an even more fundamental issue behind your joint pain that most doctors never address.
It’s not just about inflammation or wear and tear. The real culprit is a little-known protein called FIBRIN.
Fibrin is a natural protein produced by your body in response to injury. It helps form the scar tissue that’s essential for healing. But there’s a problem:
As you age, your body produces fewer and fewer of the critical enzymes needed to break down excess fibrin. By age 50, you may have lost up to 50% of these essential enzymes.
The result? Excess fibrin builds up in your joints, creating a cascade of problems:
- It triggers chronic inflammation
- It blocks blood flow, suffocating your joint tissues
- It damages your cartilage, leading to bone-on-bone grinding
This explains why conventional joint treatments often fail — they don’t address the root cause!
The Natural Solution Your Doctor
STILL Doesn’t Know About
Here’s the good news — you don’t need banned supplements to find relief. Nature already provides the perfect solution: proteolytic enzymes.
These specialized enzymes act like “drain cleaners” for your joints, breaking down excess fibrin and allowing healing nutrients to reach damaged tissues.
Heal-n-Soothe is the only formula that combines 5 powerful proteolytic enzymes with 8 natural anti-inflammatories to deliver complete joint relief in 4 different ways:
- Breaks down and dissolves excess fibrin
- Reduces inflammation naturally without side effects
- Promotes healthy blood flow for accelerated healing
- Speeds up muscle recovery to support your joints
While pharmaceutical companies focus on masking your pain with drugs, Heal-n-Soothe targets the root cause with nature’s own healing solutions.
Why Haven’t You Heard This Before?
The simple truth is there’s no money to be made by eliminating joint pain naturally with enzymes versus managing it with expensive prescription medications.
This approach was pioneered by Dr. Max Wolf at Columbia University back in the 1950s, but was ridiculed because it challenged conventional medical thinking.
Even today, it flies in the face of the $70 billion painkiller industry. That’s why most doctors don’t know about it or don’t recommend it.
But you don’t have to wait for the medical establishment to catch up. Over 1.6 million people have already experienced the life-changing benefits of Heal-n-Soothe.
And for a limited time, you can try a bottle absolutely FREE. Just tell us where to send it.
[Click Here to Claim Your FREE Bottle of Heal-n-Soothe Today]
Don’t let another day pass living with unnecessary stress and misery. Take control of your body and discover what millions already know — there’s a better way.
References:
Cholestin:
- “The Lipid-Lowering Properties of Red Yeast Rice.” AMA Journal of Ethics, June 2011. Accessed April 3, 2025. https://journalofethics.ama-assn.org/article/lipid-lowering-properties-red-yeast-rice/2011-06
- “FDA Hits Drug In Disguise.” CBS News / Associated Press, May 20, 1998. Accessed April 3, 2025. https://www.cbsnews.com/news/fda-hits-drug-in-disguise/
- “Judge Orders FDA To Lift Ban.” CBS News / Associated Press, June 16, 1998. Accessed April 3, 2025. https://www.cbsnews.com/news/judge-orders-fda-to-lift-ban/
- “Pharmanex v. Shalala.” Citeline Pharma & Medtech Business Intelligence, September 27, 1999. Accessed April 3, 2025. https://insights.citeline.com/PS090366/Pharmanex-v-Shalala/
- “FDA Hits Drug In Disguise.” CBS News / Associated Press, May 20, 1998. Accessed April 3, 2025. https://www.cbsnews.com/news/fda-hits-drug-in-disguise/
- “The Lipid-Lowering Properties of Red Yeast Rice.” AMA Journal of Ethics, June 2011. Accessed April 3, 2025. https://journalofethics.ama-assn.org/article/lipid-lowering-properties-red-yeast-rice/2011-06
- “Capitol Comments: The Cholestin Case: The Ongoing Saga.” Nutraceuticals World, June 1, 2001. Accessed April 3, 2025. https://www.nutraceuticalsworld.com/capitol-comments-the-cholestin-case-the-ongoing-sa/
Androstenedione (“Andro”):
- “‘Andro’ supplement off limits in new year.” Air Force Print News / AF.mil, Jan 4, 2005. Accessed April 3, 2025. https://www.af.mil/News/Article-Display/Article/135307/andro-supplement-off-limits-in-new-year/
- “News from DEA, Domestic Field Divisions, New York City News Releases, 09/29/09.” DEA.gov, Sept 29, 2009. Accessed April 3, 2025. https://www.dea.gov/sites/default/files/divisions/hq/2009/pr092909p.html
DMSO (Dimethyl Sulfoxide):
- “Dimethyl Sulfoxide | (CH3)2SO | CID 679.” PubChem, National Center for Biotechnology Information. Accessed April 3, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/Dimethyl-Sulfoxide
- Elisia, I., et al. “DMSO Represses Inflammatory Cytokine Production from Human Blood Cells and Reduces Autoimmune Arthritis.” PLOS ONE via PMC, March 31, 2016. Accessed April 3, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC4816398/
- Elisia, I., et al. “DMSO Represses Inflammatory Cytokine Production…” PLOS ONE via PMC, March 31, 2016. Accessed April 3, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC4816398/